A new blood test to detect cancer at an early stage has shown promising results, according to a study, as scientists aim to ...

Pancreatic cancer screening has advanced significantly in recent years. There are now research-based guidelines on screening ...

Pancreatic ductal adenocarcinoma remains a challenge to treat due to its complex biology and resistance mechanisms.

From jaundice and uncontrolled blood sugars to cancer concerns, each scenario highlights the importance of patient education ...

In its pursuit of a cancer drug for pancreatic cancer and possibly ovarian cancer, Amplia has history on its side.

A Scots dad was given a devastating cancer diagnosis after suffering persistent pain in the left side of his body. Peter ...

Peter McGovern started experiencing persistent pain in his left side in early 2023 which medics were unable to pinpoint ...

Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced the appointment of the Company's Nomination Committee.

1 The Avantect test is a blood-based assay designed to use key epigenomic and genomic signals to detect the earliest indicators of pancreatic cancer. It is targeted for use in populations at high ...